CSTF (CuraScientific) Loans Receivable: $0.00 Mil (As of Sep. 2023)


What is CuraScientific Loans Receivable?

CuraScientific CSTF -99.00% Loans Receivable is $0.00 Mil as of Sep. 2023.

CuraScientific's Loans Receivable for the quarter that ended in Sep. 2023 was $0.00 Mil.


CuraScientific Loans Receivable Historical Data

* Premium members only.

The historical data trend for CuraScientific's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CuraScientific Loans Receivable Chart

CuraScientific Annual Data
Trend Dec20 Dec21 Dec22
Loans Receivable
0.00 0.00 0.00

CuraScientific Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CuraScientific Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.00 Mil mean?
CuraScientific (CSTF) has a Loans Receivable of $0.00 Mil as of Sep. 2023. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on CuraScientific and its competitors.
Is CuraScientific's Loans Receivable too high?
CuraScientific's current Loans Receivable is $0.00 Mil.
How does CuraScientific's Loans Receivable compare to LSDIF and CLVR?
CuraScientific's Loans Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Drug Manufacturers company?
A good Loans Receivable depends on the Drug Manufacturers industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on CuraScientific and its competitors. CuraScientific's current Loans Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CuraScientific stock overvalued right now?
CuraScientific (CSTF) has a current Loans Receivable of $0.00 Mil. The current Loans Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For CuraScientific (CSTF), the current Loans Receivable is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CuraScientific Business Description

Address 12162 Riffle Road, Nevada, CA, USA, 95959
CuraScientific Corp is a bioscience company that manufactures commercial chemical products with various applications in commercial sterilization for agriculture, warehousing, hospitality and medical facilities.